NIH: Targeting Persistent HIV Reservoirs

Name: NIH: Targeting Persistent HIV Reservoirs
Application deadline: 07/04/15
General description:

Seeks approaches to efficiently monitor and specifically target reservoirs of latently infected cells to facilitate the testing of strategies to cure HIV infection in vivo. R21 phase is limited to $275,000 over the 2-years; the R33 phase is limited to $300,000 per year for three years.

http://grants.nih.gov/grants/guide/pa-files/PAR-15-041.html

 

 

Source: Foreign
Budget: R21 phase $275,000 two years
R33 phase $300,000 three years
Number of research years: 5
Contact person: Robi Guttman 2152, robertg@trdf.technion.ac.il
Fields: Life Sciences and medicine
Type of fund: The fund is a competitive fund
Related fund and profiles: National Institute of Health - NIH ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)